This is an HTML version of an attachment to the Freedom of Information request 'Meetings with the pharmaceutical industry since March 1st 2020'.



From:
SANTE PHARMACEUTICALS B5
To:
RYS Andrzej Jan (SANTE); 
SANTE); "
Bcc:
(SANTE); 
 (SANTE)
Subject:
Re: MSD"s submission removed?
Date:
lundi 24 août 2020 17:48:00
Attachments:
image004.jpg
image003.jpg
Our reference : sante.ddg1.b.5(2020)5050379
 
Dear
 
Thank you for your message to 
 concerning the unavailability of the feedback of MSD to the Pharmaceutical Strategy for Europe Roadmap.
 
The deletion of the feedback was a technical issue and not related to the content as such. Unfortunately the file attached to MSD’s response was not downloadable which meant the feedback was
automatically removed from the publicly available replies but was still accessible to the Commission. This issue has been resolved and the feedback should be available on the public webpage:
https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12421-Pharmaceutical-Strategy-Timely-patient-access-to-affordable-medicines/F536227.
 
Thank you for drawing this to our attention.
 
With kind regards,
 
Unit “Medicines: policy, authorisation and monitoring“
 
European Commission
DG Health and Food Safety
_____________
This message represents solely the views of its author and cannot be regarded as the official position of the Commission. It is intended solely for the person to whom it is addressed and may contain
confidential information. If you have received this message in error, please notify me as soon as possible.
 
 
From: "
Date: Monday, 24 August 2020 at 12:02:28
To: "
 (SANTE)" 
@ec.europa.eu>, "RYS Andrzej Jan (SANTE)" <xxxxxxx.xxx@xx.xxxxxx.xx>, 
 (SANTE)"
@ec.europa.eu>
Cc: "
Subject: MSD's submission removed?
 
Dear 
Andrzej
 
I hope this message finds you well and healthy.
 
It came to our attention that MSD’s submission to the Pharmaceutical Strategy Roadmap was removed, “as it did not comply with the EC’s rules for publishing feedback and suggestions.”
 
Could you help me understand what went wrong and how we can address this situation? I’d be happy to discuss with the appropriate person in charge of moderating this public consultation. It
would be great to know, as we’re currently preparing our responses to the Pharmaceutical Strategy survey.
 
Please see attached the verbatim of our submission for background.
 
Looking forward to hearing from you.
 
All the best,
 
 
 Michelet 92800 Puteaux - France
+33
Transparency register n°: 09824113589-92
DO YOU KNOW OUR POLICY PASSPORT?
 
 
 
 
 

 
 
 
Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., Kenilworth, N.J., U.S.A. Through our prescription
medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative
health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information,
visit www.msd.com